Showing 1 - 2 of 2
News, Apinya Wipatayotin, Published on 04/07/2025
» The Government Pharmaceutical Organisation (GPO) has prepared to register the affordable hepatitis C drug ravidasvir with the Food and Drug Administration to improve access for 800,000 patients and reduce treatment costs.
News, Apinya Wipatayotin, Published on 08/05/2018
» The first phase of clinical tests for an affordable Hepatitis C treatment has yielded a high cure rate, according to the Department of Disease Control.